NCT04876365View on ClinicalTrials.gov

A Study in Children, Teenagers and Adults With Severe Hemophilia A Who Switched From Other Factor VIII Treatments to Adynovate

CompletedOBSERVATIONAL
Enrollment

153

Participants

Timeline

Start Date

November 30, 2021

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions
Hemophilia A
Interventions
OTHER

Non-Interventional

This is a Non-Interventional Study.

Trial Locations (1)

L8N 3Z5

Hamilton-Niagara Regional Hemophilia Treatment Centre, Hamilton

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY